The Hill Ledger

US-listed stock · REGN

Regeneron Pharmaceuticals (REGN): trades by Congress and insiders

In the last 12 months, 3 members of Congress disclosed 4 trades (3 buys, 1 sale); company insiders filed 1 open-market sale.

Congress trades
412 months
Members trading
312 months
Insider buys / sales
0 / 112 months
Last close
$746.549 Oct 2026
One-year change
+31.0%

21 disclosed buys and sales on record since 30 January 2014; Congress bought an estimated $24 thousand and sold $8 thousand in the last 12 months. Insider counts are open-market trades only: awards, option exercises and tax withholding are left out.

Members of Congress who traded REGN

Last three years, by number of disclosed trades.

Latest disclosures

DisclosedFiled byTypeAmountTraded
Alan ArmstrongSenate · R-OK Buy $1K–$15K
RYAN ARTHUR FCompany insider Sale $130K
Gilbert CisnerosHouse · D-CA Sale $1K–$15K
Julia LetlowHouse · R-LA Buy $1K–$15K
Gilbert CisnerosHouse · D-CA Buy $1K–$15K
Ro KhannaHouse · D-CA Sale $1K–$15K
Ro KhannaHouse · D-CA Sale $1K–$15K
Rob BresnahanHouse · R-PA Buy $1K–$15K